Use of oral osmotic hydromorphone in opioid switch for cancer pain
Hydromorphone is a semi-synthetic opioid and it is a powerful µ receptor agonist. Hydromorphone has a short half-life (approximately 1 hour), but the controlled release formulation Oral Osmotic extends the duration of action and provides constant pain control. The aim of this study was to assess eff...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Publiediting,
2008-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|